| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
Medical Clinic and Polyclinic I [T. I., U. S. S., C. T., S. G., D. F., U. S., G. E., M. S.] and Institute of Clinical Pharmacology [U. I. S.], University Hospital of the Technical University, 01307 Dresden, Germany, and Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 37232-6602 Nashville, Tennessee [R. B. K.]
Allelic variants of the MDR-1 gene have been shown recently to influence protein expression and P-glycoprotein (P-gp) function in healthy volunteers. Therefore, 405 acute myeloid leukemia patients were investigated for somatic genotypes of the three most frequent single nucleotide polymorphisms (SNPs) in exons 12, 21, and 26. In all three loci, homozygous wild-type alleles were classified as genotype A, heterozygous as B, and homozygous mutant (alternative) allele as C. Patients with the C genotype in exons 12 and 26 showed a lower median age (both P < 0.05). Additionally, the C genotype in exons 12 and 26 was associated with cytogenetic poor risk aberrations (both P < 0.05). A possible regulatory impact of the SNPs on MDR1 mRNA expression was investigated by a Real time-PCR assay. MDR1 expression was strongly correlated with a decreased complete remission rate (P = 0.01) but failed to predict decreased overall survival (OS). There was a significant association of the A genotype in exons 21 (P = 0.05) and 26 (P < 0.05) with lower MDR1 expression, whereas the B variants showed highest MDR1 values at all three investigated gene loci. The A genotype in exon 26 was associated with lower OS (P < 0,01). In these patients, worse OS is likely attributable to an increased risk of relapse (P < 0.001). We were able to detect a linkage disequilibrium of the investigated SNPs, indicating combined polymorphisms that could affect the regulation of MDR1 expression. The A genotype of all SNPs demonstrated both lowest MDR1 values and significantly decreased OS (P < 0.05) with a high probability of relapses (P < 0.01). These observations indicate that allelic variants of the MDR1 gene may influence therapy outcome by additional mechanisms, different from P-gp expression on acute myeloid leukemia blasts, possibly involving pharmacokinetic effects of P-gp.
This article has been cited by other articles:
|
|
 |
|
  D. H. Kim, L. Sriharsha, W. Xu, S. Kamel-Reid, X. Liu, K. Siminovitch, H. A. Messner, and J. H. Lipton Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia Clin. Cancer Res., July 15, 2009; 15(14): 4750 - 4758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chang, S. Y. Rha, H. -C. Jeung, C. -K. Im, J. B. Ahn, W. S. Kwon, N. C. Yoo, J. K. Roh, and H. C. Chung Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients Ann. Onc., February 1, 2009; 20(2): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schaich, L. Kestel, M. Pfirrmann, K. Robel, T. Illmer, M. Kramer, C. Dill, G. Ehninger, G. Schackert, and D. Krex A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients Ann. Onc., January 1, 2009; 20(1): 175 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang, D. Wu, T. Bui, and R. J. Y. Ho A Novel Human Multidrug Resistance Gene MDR1 Variant G571A (G191R) Modulates Cancer Drug Resistance and Efflux Transport J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Johnatty, J. Beesley, J. Paul, S. Fereday, A. B. Spurdle, P. M. Webb, K. Byth, S. Marsh, H. McLeod, AOCS Study Group, et al. ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy Clin. Cancer Res., September 1, 2008; 14(17): 5594 - 5601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Braun, S. D. Richman, P. Quirke, C. Daly, J. W. Adlard, F. Elliott, J. H. Barrett, P. Selby, A. M. Meade, R. J. Stephens, et al. Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial J. Clin. Oncol., June 1, 2008; 26(16): 2690 - 2698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Seedhouse, M. Grundy, P. White, Y. Li, J. Fisher, D. Yakunina, A. V. Moorman, T. Hoy, N. Russell, A. Burnett, et al. Sequential Influences of Leukemia-Specific and Genetic Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the National Cancer Research Network Acute Myeloid Leukemia 14 and 15 Trials Clin. Cancer Res., December 1, 2007; 13(23): 7059 - 7066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein) Oncologist, August 1, 2007; 12(8): 927 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, J. Wang, E. Tantoso, B. Wang, A. Y.P. Tai, L. L.P.J. Ooi, S. S. Chong, and C. G.L. Lee Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci Hum. Mol. Genet., June 1, 2007; 16(11): 1367 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Weiss, M. R. Baer, C. B. Ambrosone, J. G. Blanco, A. Hutson, L. A. Ford, and K. B. Moysich Concordance of Pharmacogenetic Polymorphisms in Tumor and Germ Line DNA in Adult Patients with Acute Myeloid Leukemia Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 1038 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wrensch, A. McMillan, J. Wiencke, J. Wiemels, K. Kelsey, J. Patoka, H. Jones, V. Carlton, R. Miike, J. Sison, et al. Nonsynonymous Coding Single-Nucleotide Polymorphisms Spanning the Genome in Relation to Glioblastoma Survival and Age at Diagnosis Clin. Cancer Res., January 1, 2007; 13(1): 197 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Monzo, S. Brunet, A. Urbano-Ispizua, A. Navarro, G. Perea, J. Esteve, R. Artells, M. Granell, J. Berlanga, J. M. Ribera, et al. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia Blood, June 15, 2006; 107(12): 4871 - 4879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Sohn, S. Y. Lee, S. J. Lee, E. J. Kim, S. I. Cha, C. H. Kim, J.-T. Lee, T. H. Jung, and J. Y. Park MDR1 Polymorphisms Predict the Response to Etoposide-Cisplatin Combination Chemotherapy in Small Cell Lung Cancer Jpn. J. Clin. Oncol., March 1, 2006; 36(3): 137 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Song, J. K. Lamba, L. Zhang, E. Schuetz, N. Shukla, B. Meibohm, and C. R. Yates G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 (MDR1) Expression. J. Clin. Pharmacol., March 1, 2006; 46(3): 373 - 379. [Full Text] [PDF]
|
|
|
|
|
|
H. Green, P. Soderkvist, P. Rosenberg, G. Horvath, and C. Peterson mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy Clin. Cancer Res., February 1, 2006; 12(3): 854 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Isla, C. Sarries, R. Rosell, G. Alonso, M. Domine, M. Taron, G. Lopez-Vivanco, C. Camps, M. Botia, L. Nunez, et al. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer Ann. Onc., August 1, 2004; 15(8): 1194 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tang, L. P. Wong, E. J.D. Lee, S. S. Chong, and C. G.L. Lee Genomic evidence for recent positive selection at the human MDR1 gene locus Hum. Mol. Genet., April 15, 2004; 13(8): 783 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Lockhart, R. G. Tirona, and R. B. Kim Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy Mol. Cancer Ther., July 1, 2003; 2(7): 685 - 698. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
